SEC 13F Intelligence

Managers / Q3 2023 · view latest →

Siguler Guff Advisers, LLC

CIK 0001328551 · 200 PARK AVENUE, 14TH FLOOR, NEW YORK, NY, 10166 · 212 332-5100

Reported Value
$196M
Q3 2023
Positions
6
Filings on Record
11
2019–present window
Filed
Oct 19, 2023
original filing

Summary

Siguler Guff Advisers, LLC reported $196M in U.S.-listed holdings across 6 positions for Q3 2023.

The portfolio is heavily concentrated: RPRX alone accounts for 47.0% of reported value.

Compared with Q2 2023, the fund opened 0 new positions and exited 1.

Portfolio Metrics

Turnover
0.0%
vs prior filed quarter
Largest Position
+47.0%
Royalty Pharma

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’23: $256MQ1 ’23Q2 ’23: $226MQ3 ’23: $196MQ3 ’23Q4 ’23: $250MQ1 ’24: $251MQ1 ’24Q2 ’24: $233MQ3 ’24: $269MQ3 ’24Q4 ’24: $201MQ1 ’25: $72MQ1 ’25Q2 ’25: $70MQ3 ’25: $56MQ3 ’25filingsflow.com

Portfolio Composition

By security type
Common Stock: 90.8%REIT: 6.7%Other: 2.4%
  • Common Stock · 90.8% · $178M
  • REIT · 6.7% · $13M
  • Other · 2.4% · $5M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
TOSTTOAST INCSOLD OUT60.4K0$1M$0
FATHOM DIGITAL MFG CORPTRIMMED15.80M831.7K$2M$5M
RPRXROYALTY PHARMA PLCHELD+03.39M$12M$92M
SEMRUSH HLDGS INCHELD+07.27M$8M$62M
FYBRFRONTIER COMMUNICATIONS PAREHELD+01.43M$4M$22M
SVCSERVICE PPTYS TRHELD+01.71M$2M$13M
PNBKPATRIOT NATL BANCORP INCHELD+0299.7K$840,215$2M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2023

6 positions
#IssuerClass% PortfolioValueShares
1RPRXROYALTY PHARMA PLChistory →SHS CL A47.04%$92M3.39M
2SEMRUSH HLDGS INCCL A COM31.59%$62M7.27M
3FYBRFRONTIER COMMUNICATIONS PAREhistory →COM11.43%$22M1.43M
4SVCSERVICE PPTYS TRhistory →COM SH BEN INT6.72%$13M1.71M
5FATHOM DIGITAL MFG CORPCLA A COM2.44%$5M831.7K
6PNBKPATRIOT NATL BANCORP INCCOM NEW0.78%$2M299.7K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2025$56M2Oct 15, 202513F-HRchanges · EDGAR ↗
Q2 2025$70M2Jul 29, 202513F-HRchanges · EDGAR ↗
Q1 2025$72M2Apr 29, 202513F-HRchanges · EDGAR ↗
Q4 2024$201M4Jan 23, 202513F-HRchanges · EDGAR ↗
Q3 2024$269M5Oct 28, 202413F-HRchanges · EDGAR ↗
Q2 2024$233M5Jul 25, 202413F-HRchanges · EDGAR ↗
Q1 2024$251M6Apr 26, 202413F-HRchanges · EDGAR ↗
Q4 2023$250M6Jan 29, 202413F-HRchanges · EDGAR ↗
Q3 2023$196M6Oct 19, 202313F-HRchanges · EDGAR ↗
Q2 2023$226M7Jul 31, 202313F-HRchanges · EDGAR ↗
Q1 2023$256M6May 5, 202313F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.